Andrew Stewart Plump, Director, President, Research and Development, on September 02, 2026, sold 116,191 shares in Takeda Pharmaceutical (TAK) for $2,148,372. Following the Form 4 filing with the SEC, Plump has control over a total of 912,034 American depositary shares of the company, with 766,569 shares held directly and 145,465 controlled indirectly.
SEC Filing: